110 related articles for article (PubMed ID: 33377218)
1. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
van Haren FMP; Richardson A; Yoon HJ; Artigas A; Laffey JG; Dixon B; Smith R; Vilaseca AB; Barbera RA; Ismail TI; Mahrous RS; Badr M; De Nucci G; Sverdloff C; van Loon LM; Camprubi-Rimblas M; Cosgrave DW; Smoot TL; Staas S; Sann K; Sas C; Belani A; Hillman C; Shute J; Carroll M; Wilkinson T; Carroll M; Singh D; Page C
Br J Clin Pharmacol; 2021 Aug; 87(8):3075-3091. PubMed ID: 33377218
[TBL] [Abstract][Full Text] [Related]
2. Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies.
van Haren FMP; Laffey JG; Artigas A; Page C; Schultz MJ; Cosgrave D; McNicholas B; Smoot TL; Nunes Q; Richardson A; Yoon HJ; van Loon LM; Ghosh A; Said S; Panwar R; Smith R; Santamaria JD; Dixon B;
Br J Clin Pharmacol; 2022 Jul; 88(7):3272-3287. PubMed ID: 35106809
[TBL] [Abstract][Full Text] [Related]
3. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study.
DeNucci G; Wilkinson T; Sverdloff C; Babadopulos T; Woodcock A; Shute J; Renato Guazelli P; Gerbase LF; Mourão PAS; Singh D; van Haren FMP; Page C
Pulm Pharmacol Ther; 2023 Jun; 80():102212. PubMed ID: 36990381
[TBL] [Abstract][Full Text] [Related]
5. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
van Haren FMP; Page C; Laffey JG; Artigas A; Camprubi-Rimblas M; Nunes Q; Smith R; Shute J; Carroll M; Tree J; Carroll M; Singh D; Wilkinson T; Dixon B
Crit Care; 2020 Jul; 24(1):454. PubMed ID: 32698853
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients.
van Haren FMP; van Loon LM; Steins A; Smoot TL; Sas C; Staas S; Vilaseca AB; Barbera RA; Vidmar G; Beccari H; Popilevsky F; Daribayeva E; Venkatesan B; Mozes S; Postel R; Popilevski N; Webb A; Nunes Q; Laffey JG; Artigas A; Smith R; Dixon B; Richardson A; Yoon HJ; Page C
Br J Clin Pharmacol; 2022 Jun; 88(6):2802-2813. PubMed ID: 34984714
[TBL] [Abstract][Full Text] [Related]
7. PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.
Mollerup A; Larsen SC; Bennetzen AS; Henriksen M; Simonsen MK; Weis N; Kofod LM; Heitmann BL
BMJ Open; 2021 Jun; 11(6):e050582. PubMed ID: 34193503
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
9. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
[TBL] [Abstract][Full Text] [Related]
10. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
11. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.
Tavernier E; McNicholas B; Pavlov I; Roca O; Perez Y; Laffey J; Mirza S; Cosgrave D; Vines D; Frat JP; Ehrmann S; Li J
BMJ Open; 2020 Nov; 10(11):e041520. PubMed ID: 33177145
[TBL] [Abstract][Full Text] [Related]
12. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
13. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).
Lei C; Su B; Dong H; Bellavia A; Fenza RD; Fakhr BS; Gianni S; Grassi LG; Kacmarek R; Morais CCA; Pinciroli R; Vassena E; Berra L
medRxiv; 2020 May; ():. PubMed ID: 32511534
[TBL] [Abstract][Full Text] [Related]
14. Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial.
Zheng Z; Wang L; Wang S; Fan Q; Zhang H; Luo G; Gao B; Yang X; Zhao B; Wang X; Dong H; Nie H; Lei C
BMJ Open; 2024 Mar; 14(3):e077572. PubMed ID: 38485487
[TBL] [Abstract][Full Text] [Related]
15. ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial.
Denholm JT; Venkatesh B; Davis J; Bowen AC; Hammond NE; Jha V; McPhee G; McQuilten Z; O'Sullivan MVN; Paterson D; Price D; Rees M; Roberts J; Jones M; Totterdell J; Snelling T; Trask N; Morpeth S; Tong SY;
Trials; 2022 Dec; 23(1):1014. PubMed ID: 36514143
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy.
Oliynyk O; Barg W; Slifirczyk A; Oliynyk Y; Dubrov S; Gurianov V; Rorat M
Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685403
[TBL] [Abstract][Full Text] [Related]
17. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.
Files DC; Matthay MA; Calfee CS; Aggarwal NR; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD; ;
BMJ Open; 2022 Jun; 12(6):e060664. PubMed ID: 35667714
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Related Coagulopathy: What is Known Up to Now.
Pena ALB; Oliveira RA; Severo RG; Simões E Silva AC
Curr Med Chem; 2021; 28(21):4207-4225. PubMed ID: 33019920
[TBL] [Abstract][Full Text] [Related]
19. Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia.
Ball L; Schultz MJ; Pelosi P
Lancet Respir Med; 2021 Apr; 9(4):321-322. PubMed ID: 33493452
[No Abstract] [Full Text] [Related]
20. Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management.
Vitaliti G; Giacchi V; Sciacca M; Ruggieri M; Falsaperla R
Expert Rev Hematol; 2022 Jul; 15(7):635-643. PubMed ID: 35757861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
